Serum Sickness in Patients Receiving Equine Rabies Immunoglobulin
Journal Title: Journal of Communicable Diseases - Year 2018, Vol 50, Issue 2
Abstract
Background: Equine Rabies Immunoglobulin (ERIG) is being used for treatment of category-III animal bite cases. ERIG is economical as compared to Human Rabies Immunoglobulin (HRIG) and hence more affordable to patients in developing countries, like India. Despite high degree of purification, there are reported cases of serum sickness like reactions, anaphylaxis, and other allergic reactions following ERIG administration. Serum sickness is a type III or immune-complex-mediated hypersensitivity reaction that results from the injection of heterologous or foreign protein or serum. Because of fear of side effects (including serumsickness-like reaction) following ERIG, the use of ERIG is minimal among doctors. Objective: (1) To assess the incidence of serum sickness following the administration of ERIG. (2) To see the clinical features of serum sickness. Methods: This is a hospital-based cross-sectional study carried out in the ARV OPD of SCB Medical College, Cuttack, Odisha, India. All patients who received ERIG between September 2016 and December 2016 were included in the study. Side effects were monitored during the subsequent follow-up visits. Results: Out of 1548 category-III animal bite cases who received ERIG, 3.1% developed serum-sickness-like reactions, which manifested as rashes in 97.82%. Most of them had symptoms after seventh day following ERIG administration. Symptomatic relief with oral antihistamines like Cetirizine, Levocetirizine in 60% of cases and Inj. Avil (chlorpheniramine maleate) in 17% was achieved, and only one case required shortcourse corticosteroids. Conclusion: Despite 3.1% of serum sickness cases reported in our present study, the safety of ERIG has been proved and serum sickness can be managed with oral analgesics and antihistamines. Hence ERIG should be encouraged among doctors for use in category-III animal bite patients to prevent rabies.
Authors and Affiliations
Dr. Tapas Ranjan Behera
Keywords
Related Articles
- EP ID EP294959
- DOI 10.24321/0019.5138.201811
- Views 105
- Downloads 0
Isolation and Characterization of Antimycobacterial Compounds from Fruits of Aegle marmelos (L.) Correa
Root extracts of Aegle marmelos, an evergreen tree indigenous to India, is an important ingredient in Ayurvedic preparations used for the treatment of pulmonary tuberculosis. Leaves of the tree are used as a remedy for r...
A New Approach to Evaluate Quality Adjusted Life Years Using Proxy Utility Function - An Application to HIV/ AIDS Data
Estimation of Quality Adjusted Life Years (QALYs) is pivotal towards economic evaluation and cost-effectiveness analysis of medical interventions. Most of the methods developed till date for calculating QALYs are based o...
Contamination Status of Hospitals and Health Care Centers by Rodents (Rodentia: Muridae) in Iran
Introduction: Rats are considered as an important potential reservoir for some zoonotic diseases and have an important role in the transmission and spreading them. This research was performed with the purpose of studying...
An Epidemiological Study to Assess the Environmental and Socio-Cultural Determinants of Malaria in Coastal Karnataka
Background: India has grappled with the problem of malaria since many decades. Moreover, Udupi district contributes 13% of malaria cases to Karnataka making it a significant public health concern. Objectives: To explore...
Epidemiology of Diarrhea among under-five Children in a Village in Sunderbans, South 24 Parganas, West Bengal, India
Background: Though various studies have been carried out on the problem of diarrheal disease in under-five children in various parts of India, no comprehensive study has so far been done on this problem in deltaic region...